Purchase Order N3239819P0037
Award Date
8/26/19
Potential Completion Date
9/16/19
Potential Value
$250K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of a MiSeq System sequencer. The award does not have a set-aside designation and has a ceiling value of $95,931. Illumina has a history of providing sequencing systems and related products and services to...
This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
This firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $81,810 contract is for the provision of a MiSeq instrument, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and bioinformatics support to various federal agencies for research and diagnostic applications. This order falls under Illumina's $3.3...
This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...